Sumitra Deb
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Polyomavirus and related diseases
- Biotechnology top 1%
- Cancer Research and Treatments
Papers in
- Oncology 56
- Cancer-related Molecular Pathways 42
- Polyomavirus and related diseases 11
-
- Epigenetics and DNA Methylation 14
- RNA modifications and cancer 13
- Co-authors
- P Tegtmeyer (10 shared papers)Mark A. Subler (12 shared papers)Daniel W. Martin (8 shared papers)Swati Palit Deb (30 shared papers)A L DeLucia (5 shared papers)Doris Brown (11 shared papers)Andrew Koff (4 shared papers)Raquel Muñoz (4 shared papers)
- Journals
- Journal of Virology (12 papers)Molecular and Cellular Biology (8 papers)Oncogene (6 papers)Sub-cellular biochemistry (4 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Sumitra Deb
75 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 93
- Oncology 2.2k
- Biotechnology 424
- Molecular Biology 2.0k
- Cancer Research 399
- Virology 119
Countries citing papers authored by Sumitra Deb
This map shows the geographic impact of Sumitra Deb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumitra Deb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumitra Deb more than expected).
Fields of papers citing papers by Sumitra Deb
This network shows the impact of papers produced by Sumitra Deb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumitra Deb. The network helps show where Sumitra Deb may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumitra Deb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 165 | |
| 2 | 2013 | 162 | |
| 3 | 1986 | 159 | |
| 4 | 1996 | 158 | |
| 5 | 1985 | 155 | |
| 6 | 1986 | 152 | |
| 7 | 1992 | 147 | |
| 8 | 1986 | 127 | |
| 9 | 1987 | 125 | |
| 10 | 2011 | 106 | |
| 11 | 1995 | 105 | |
| 12 | 2004 | 104 | |
| 13 | 2004 | 103 | |
| 14 | 1993 | 101 | |
| 15 | 1987 | 91 | |
| 16 | Wild-type human p53 activates the human epidermal growth factor receptor promoter. | 1994 | 87 |
| 17 | 1987 | 82 | |
| 18 | 1998 | 75 | |
| 19 | 1986 | 72 | |
| 20 | 2007 | 63 |
About Sumitra Deb
Sumitra Deb is a scholar working on Oncology, Molecular Biology, Biotechnology, Genetics and Epidemiology, having authored 75 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (42 papers), Epigenetics and DNA Methylation (14 papers), RNA modifications and cancer (13 papers), Virus-based gene therapy research (12 papers), Cancer Research and Treatments (12 papers), Polyomavirus and related diseases (11 papers), Herpesvirus Infections and Treatments (9 papers) and Bacteriophages and microbial interactions (9 papers). The work is most often cited by research in Oncology (2.2k citations), Biotechnology (424 citations), Molecular Biology (2.0k citations), Cancer Research (399 citations) and Virology (119 citations). Sumitra Deb has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include P Tegtmeyer, Mark A. Subler, Daniel W. Martin, Swati Palit Deb, A L DeLucia, Doris Brown, Andrew Koff, Raquel Muñoz, Catherine A. Vaughan and W. Andrew Yeudall. Their work appears in journals such as Journal of Virology, Molecular and Cellular Biology, Oncogene, Sub-cellular biochemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.